Is this you? Create Your Porfile
Avatar

Mark Lebwohl

University of Utah

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mark Lebwohl is active.

Explore More

Publication

Featured researches published by Mark Lebwohl.

Archive | 2008

Moderate-to-Severe Psoriasis, Third Edition

John Koo; Chai Lee; Mark Lebwohl; Gerald Weinstein; Alice Gottlieb

Moderate-to-severe psoriasis / , Moderate-to-severe psoriasis / , کتابخانه دیجیتال جندی شاپور اهواز

Archives of Dermatology | 2001

The Impact of Psoriasis on Quality of Life: Results of a 1998 National Psoriasis Foundation Patient-Membership Survey

Gerald G. Krueger; John Koo; Mark Lebwohl; Alan Menter; Robert S. Stern; Tara Rolstad

Archive | 2006

Mild-to-Moderate Psoriasis

John Koo; Mark Lebwohl; Chai Lee

SKIN The Journal of Cutaneous Medicine | 2017

Improvement of Nail Psoriasis with Brodalumab in Phase 3 Trials

Mark Lebwohl; Lawrence Green; Sylvia Hsu; Shipra Rastogi; Tina Lin; Radhakrishnan Pillai; Robert J Israel

/data/revues/01909622/v78i1/S0190962217322569/ | 2017

Iconography : Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials

Mark Lebwohl; K.A. Papp; Lauren B. Marangell; John Koo; Andrew Blauvelt; Melinda Gooderham; Jashin J. Wu; Shipra Rastogi; Susan Harris; Radhakrishnan Pillai; Robert J Israel

Archive | 2014

Mild to Moderate Psoriasis, Third Edition

John Koo; Ethan Levin; Argentina Leon; Jashin Wu; Mark Lebwohl

/data/revues/01909622/v69i3/S0190962213003125/ | 2013

Iconography : A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis

Mark Lebwohl; Leon Kircik; Kristina Callis Duffin; David M. Pariser; Michele Hooper; Deborah Wenkert; Elizabeth H. Thompson; Jun Yang; Greg Kricorian; John Koo

/data/revues/01909622/v50i3sS/S0190962203038957/ | 2011

Global safety and efficacy of more than 5 years of etanercept therapy in rheumatoid arthritis

Mark Lebwohl; Alice Gottlieb; Wayne Wallis; Ralph Zitnik

/data/revues/01909622/v50i3sS/S0190962203038921/ | 2011

A multi-center study of calcipotriene 0.005% ointment and clobetasol proprionate 0.05% foam in the sequential treatment of localized plaque-type psoriasis

Robin R. Blum; Dana K. Stern; John Koo; Mark Lebwohl

/data/revues/01909622/v50i3sS/S019096220303891X/ | 2011

Continuance on etanercept after early incomplete response in patients with psoriasis

Gerald G. Krueger; Mark Lebwohl; Andrea Wang; Ralph Zitnik

Explore More

Collaboration

Dive into the Mark Lebwohl's collaboration.

Top Co-Authors
Avatar

John Koo

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors
Avatar

Alice Gottlieb

Robert Wood Johnson University Hospital

View shared research outputs
Top Co-Authors
Avatar

Chai Sue Lee

University of California

View shared research outputs
Top Co-Authors
Avatar

Ralph Zitnik

Amgen

View shared research outputs
Top Co-Authors
Avatar

Gerald G. Krueger

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors
Avatar

Lawrence Green

George Washington University

View shared research outputs
Top Co-Authors
Avatar

Radhakrishnan Pillai

Valeant Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Alan Menter

University of Utah

View shared research outputs
Top Co-Authors
Avatar

Andrew Blauvelt

Oregon Health

View shared research outputs
Top Co-Authors
Avatar

Argentina Leon

University of California

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge